T1	intervention 0 17	Physical Activity
T2	outcome 944 961	No adverse events
T3	total-participants 582 590	Fourteen
T4	eligibility 591 625	women with metastatic breast cance
T7	outcome 1133 1195	Functional Assessment of Chronic Illness Therapy-Fatigue score
T8	outcome 1239 1245	VO2max
T9	outcome 1342 1362	six-minute walk test
T5	outcome 1582 1596	well tolerated
T16	outcome 1513 1530	feasible and safe
T17	outcome 846 855	Adherence
T18	iv-bin-percent 916 920	100%
T19	iv-bin-percent 925 928	25%
T6	control 655 668	control group
T10	iv-cont-mean 1197 1201	+5.6
T20	iv-cont-sd 1204 1207	3.2
T11	cv-cont-mean 1212 1216	-1.8
T21	cv-cont-sd 1219 1222	3.9
T12	iv-cont-mean 1247 1264	+1.6 ml/kg/minute
T22	iv-cont-sd 1266 1282	1.8 mL/kg/minute
T13	cv-cont-mean 1287 1304	-0.2 mL/kg/minute
T23	cv-cont-sd 1306 1322	0.1 mL/kg/minute
T14	iv-cont-mean 1364 1369	+40 m
T24	iv-cont-sd 1372 1376	23 m
T15	cv-cont-mean 1381 1386	-46 m
T25	cv-cont-sd 1389 1393	56 m
